RefleXion X1 Radiotherapy System Model RXM1000 Software version 2.1.19-3 Radiation therapy system is a device that combines the functionality of an emission computed tomography detection system and a linear accelerator.
Published June 5, 2024 · Recall initiated: April 16, 2024
Summary
FDA records medical device Class II recall Z-1933-2024, published June 5, 2024 and initiated April 16, 2024. Recalling firm: Reflexion Medical, Inc.; Status: Ongoing; Reported quantity: 7 systems; Lot: Model Number: RXM1000 UDI Codes that includes system serial numbers: (01)00860003983812(11)230504(21)X11001 (01)00860003983812(11)230518(21)X11002 (01)00860003983812(11)230505(21)X11003 (01)00860003983812(11)230530(21)X11004 (01)00860003983812(11)230811(21)X11006 (01)00860003983812(11)230410(21)X11007 (01)00860003983812(11)230803(21)X11008. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A potential dose error exists for patients treated with an out of session SCINTIX partial fraction.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Reflexion Medical, Inc.
- Distributor
- U.S.: CA, CT, NJ, OR, PA and TX No O.U.S.
- Lot
- Model Number: RXM1000 UDI Codes that includes system serial numbers: (01)00860003983812(11)230504(21)X11001 (01)00860003983812(11)230518(21)X11002 (01)00860003983812(11)230505(21)X11003 (01)00860003983812(11)230530(21)X11004 (01)00860003983812(11)230811(21)X11006 (01)00860003983812(11)230410(21)X11007 (01)00860003983812(11)230803(21)X11008
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDARizatriptan Benzoate Tablets USP, 5mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: GlenmarkJune 12, 2024
- FDARizatriptan Benzoate Tablets USP, 10 mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: GlenmarkJune 12, 2024
- FDARizatriptan Benzoate Orally Disintegrating Tablets, USP 5mg, 18 (3 x 6) Unit-Dose Tablets, Manufactured for:June 12, 2024
- FDABD Pyxis(TM) Anesthesia Station 4000, REF: 338June 5, 2024
- FDABD Pyxis" Anesthesia Station ES, REF: 327June 5, 2024
- FDABD Pyxis MedStation 4000 7-Drawer Auxiliary Tower, REF: 306June 5, 2024
Questions about this recall
Was RefleXion X1 Radiotherapy System Model RXM1000 Software version 2.1.19-3 Radiation therapy system is a device that combines the functionality of an emission computed tomography detection system and a linear accelerator. recalled?
Yes. FDA published recall Z-1933-2024 on June 5, 2024. Reported hazard: A potential dose error exists for patients treated with an out of session SCINTIX partial fraction.
What should I do if I have this product?
Voluntary: Firm initiated · Letter